OncoScreen-L
OncoScreen-L Rapid Test Panel for Early Lung Cancer Detection Overview:OncoScreen-L is a cutting-edge rapid diagnostic panel developed by OncoFirm Diagnostics, designed to support the early detection of lung cancer in…
-
-
OncoScreen-B
OncoScreen-B Rapid Test for Breast and Ovarian Cancer Detection Overview:OncoScreen-B is an advanced rapid diagnostic test developed by OncoFirm Diagnostics for the early detection of breast and ovarian cancers. Powered…
-
OncoScreen-R
OncoScreen-R: Rapid test for colorectal and pancreatic cancers. OncoScreen-R Rapid Test for Colorectal and Pancreatic Cancer Detection Overview:OncoScreen-R is a high-performance lateral flow rapid test developed by OncoFirm Diagnostics, designed…
-
Applications | Our Newsroom - Posts, Stories and Strategies... | Our Research Areas - Human Cancer Antigens | Technology
Thomsen-Friedenreich (TF) antigen
Thomsen–Friedenreich (TF) Antigen: A Key Marker in Cancer Biology The Thomsen–Friedenreich (TF) antigen, also known as CD176, is a simple two‑sugar structure (galactose + N‑acetylgalactosamine) normally hidden on healthy cells….
-
PR NEWSWIRE 2025 – Revolutionizing Early Cancer Detection
ONCOFIRM DIAGNOSTICS — April 1, 2025 Revolutionizing Early Cancer Detection ONCOFIRM DIAGNOSTICS is transforming the future of cancer screening with next‑generation lateral flow assay (LFA) technology. By integrating advanced nanoparticle…
-
KRAS Mutations
KRAS mutations are among the most common oncogenic drivers in human cancers, notably in pancreatic, colorectal, and lung cancers. The KRAS gene encodes a protein that functions as a molecular…
-
TP53 (Tumor Protein p53)
TP53 (Tumor Protein p53)
-
AFP (Alpha-Fetoprotein)
Alpha-Fetoprotein (AFP) is a well-established cancer biomarker with diverse clinical applications, especially in liver and germ cell tumors. Here’s a detailed summary of its biological role, diagnostic value, prognostic utility,…
-
PSA (Prostate-Specific Antigen)
Prostate-Specific Antigen (PSA) is a widely used cancer biomarker, particularly for prostate cancer (PCa). While it has transformed prostate cancer screening and monitoring, it also has notable limitations. Here’s a…
-
CEA (Carcinoembryonic Antigen)
CEA is a cell adhesion molecule normally produced during fetal development. In adults, it is usually undetectable in the blood, but it may be re-expressed and elevated in certain cancers,…
